Title : Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.

Pub. Date : 2017 Mar 16

PMID : 28049639






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Disease progression in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib has been attributed to histologic transformation or acquired mutations in BTK and PLCG2. ibrutinib phospholipase C gamma 2 Homo sapiens